Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AlfaCognition: Longitudinal Study for the Characterization of the Phases of Subjective Perception of Cognitive Decline and Mild Cognitive Impairment of Alzheimer's Disease.

NCT03851523 is registered in ClinicalTrials.gov with Barcelonabeta Brain Research Center, Pasqual Maragall Foundation as lead sponsor.

NCT NCT03851523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03851523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AlfaCognition: Longitudinal Study for the Characterization of the Phases of Subjective Perception of Cognitive Decline and Mild Cognitive Impairment of Alzheimer's Disease.
Lead sponsor
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Phase
Observational
Overall status
Recruiting
Start date
February 12, 2018
Completion date
December 31, 2027
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, mild cognitive impairment, subjective cognitive decline